214370 — Caregen Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual income statement for Caregen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	60,295	59,088	69,098	79,210	82,586
Cost of Revenue
Gross Profit	48,644	45,537	52,346	58,363	55,317
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	28,317	30,816	35,472	38,832	47,990
Operating Profit	31,978	28,272	33,626	40,378	34,596
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	36,084	33,581	34,457	49,572	40,167
Provision for Income Taxes
Net Income After Taxes	31,449	25,184	27,217	39,930	32,314
Minority Interest
Net Income Before Extraordinary Items
Net Income	31,478	25,318	27,267	39,930	32,314
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	31,478	25,318	27,267	39,930	32,314
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	635	515	556	813	653
Dividends per Share